Next Article in Journal
Metabolic Changes in Zebrafish Larvae Infected with Mycobacterium marinum: A Widely Targeted Metabolomic Analysis
Previous Article in Journal
Amino Acid Metabolism in Liver Mitochondria: From Homeostasis to Disease
Previous Article in Special Issue
Soil Salinity, a Serious Environmental Issue and Plant Responses: A Metabolomics Perspective
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metabolomic Prediction of Naphthalene Pneumo-Toxicity in the Snail Helix aspersa maxima

Laboratory of Human Biology & Toxicology, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium
*
Author to whom correspondence should be addressed.
Metabolites 2025, 15(7), 448; https://doi.org/10.3390/metabo15070448
Submission received: 26 May 2025 / Revised: 20 June 2025 / Accepted: 26 June 2025 / Published: 3 July 2025
(This article belongs to the Collection Feature Papers in Assessing Environmental Health and Function)

Abstract

Background: Polluted soils represent a major problem in many industrialized countries that urgently requires appropriate health risk assessment. The One Health concept that considers a close relationship between human and animal health and ecosystems relies, among other techniques, on continuous monitoring through the use of animal species as bioindicators. In this context, terrestrial gastropods, already recognized as relevant indicators due to their anatomo-physiology, provide a reliable model to study the pneumotoxic effects of pollutants. On the other hand, risk assessment is based on multi-biomarker studies. Therefore, omic approaches seem particularly useful since they can simultaneously detect numerous early biological changes. Methods: In this study, Helix aspersa maxima was exposed to naphthalene, a highly volatile aromatic hydrocarbon responsible for numerous respiratory disorders. Pulmonary membrane extracts and hemolymph samples were analyzed by 1H-NMR spectroscopy after single or repeated exposures to naphthalene. Results: Numerous metabolic changes were observed, which could be related to membrane lesions, energy, anti-inflammatory, and tumorigenesis pathways. Conclusions: Our findings highlight the potential of combining animal indicator and omics techniques to predict respiratory health risks in cases of exposure to polluted soils.

1. Introduction

Anthropic pollution is a major public health issue in many industrialized countries, requesting soil restoration and continuous health risk assessment. Contaminated soils can impact all living organisms via various exposure routes, including inhalation of volatile compounds such as polycyclic aromatic hydrocarbons (PAHs). The “One Health Concept” considers a close relationship between human and animal health and ecosystems, showing an interest in combining human health and environmental risk assessments. Therefore, it is more and more accepted that the management of polluted soils should include animal species as bioindicators to anticipate human health risks.
For more than thirty years, gastropod mollusks have been recognized as relevant ecological indicators [1,2,3,4,5,6] because they represent a significant biomass of the soil community and have a global distribution [7]. Additionally, they integrate multiple sources and pathways of contamination thanks to their presence in the soil–plant–air interface [8]; they have significant bioaccumulation capacities for many pollutants, whether of metallic [9,10,11] or organic origin [12,13]; they exhibit physiological and biochemical responses upon exposure to xenobiotics [12,14,15]; and finally, they constitute a key element of the food chain reflecting the transfer of pollutants within trophic networks [16,17,18]. Land snails, such as Helix aspersa maxima (Taylor, 1883) [19], classified as pulmonated organisms, have a vascularized epithelium acting as a lung, lining the mantle cavity and receiving oxygen via the pneumostome. As such, they represent an appropriate model to assess respiratory risks of exposure to atmospheric pollutants.
Nowadays, effective health risk monitoring using a bioindicator model is expected to be based on a multi-biomarker approach [20,21,22]. In this context, 1H-NMR- and MS-based metabolomics can give a simultaneous and global assessment of the alterations in the metabolome in one single analysis. It is also seen as one of the few techniques able to help transpose animal findings to humans since most of the cellular biochemical pathways are conserved through evolution [23,24], one major goal of the “One Health Concept”. Recent studies have shown the advantages of using the 1H-NMR-based metabolomics approach in air pollution research through the exploration of metabolic alterations in various biofluids [25,26], including bronchial alveolar lavage fluid (BALF) [27,28]. Such protocols allowed the early detection of metabolic changes mirroring increased oxidative stress, airway inflammation, and endothelial dysfunction.
Naphthalene, one of the carcinogenic PAHs to which humans are most exposed through various sources, including industrial waste, vehicle emissions, or tobacco smoking, is known to cause histological damages in airway epithelia associated with Clara cell necrosis [29,30,31,32]. Mechanistically, the toxicological properties of naphthalene are directly attributed to cytotoxicity and indirectly to genotoxicity after liver bioactivation and distribution of the reactive metabolites to the lungs via the systemic bloodstream [33,34,35]. After repeated and/or long-term exposures to naphthalene, naphthalene-induced cell necrosis can lead to tumor development in mammals. Interestingly, tumorigenesis is a pathological process also encountered in mollusks [36,37,38,39,40],
A couple of studies using 1H-NMR spectroscopy have already monitored naphthalene-induced biochemical changes in the respiratory system of rodents after intraperitoneal exposure [41,42]. Interestingly, some tolerance against naphthalene after repeated exposures was reported in mice, underlying the important role of the glutathione S-transferase (GST) enzyme in the detoxifying process [43]. GSTs are phase II conjugation enzymes in xenobiotic metabolism whose main role is to conjugate GSH to compounds containing an electrophilic moiety, as is the case in PAHs, and are found in many invertebrates such as terrestrial mollusks [33,44,45,46,47].
In this study, we monitored by 1H-NMR spectroscopy the changes induced in the bioindicator snail model after single and repeated exposures to naphthalene, with a special focus on early metabolic markers of respiratory damage and tumorigenesis. GST measurement was used as an indicator of naphthalene exposure and metabolism.

2. Materials and Methods

2.1. Animal Housing

Helix aspersa maxima individuals purchased from the helicicole farm of Avesnois (Croix-Caluyau, France) were housed in a homemade breeding housing, allowing permanent access to water and professional food farming provided by Helinove product (France). They were kept at a temperature of 20 ± 2 °C and daylighting. Only adults with close age and body weight (~20 g) were investigated. A total of 36 snails were used in this study, with 6 individuals per group.

2.2. Chemicals

The following compounds were used for the preparation and analysis of the samples: phosphate buffer–D2O prepared with Na2HPO4·2H2O 0.2 M and NaH2PO4.H2O 0.04 M in distilled water–deuterium oxide (D2O) solution (80:20, v:v); methanol; chloroform; TSP (deuterated sodium 3-trimethylsilyl propionate); DMSO (dimethyl sulfoxide 99,5%); phosphate buffer–EDTA prepared with Na2HPO4.2H2O 0.2 M, NaH2PO4.H2O 0.04 M, and EDTA (ethylene diamine tetra-acetic acid) 1 mM in distilled water; dye reagent concentrate for protein assay (5000006 from BIORAD, Hercules, CA, USA); bovine serum albumin (BSA); glutathione S-transferase assay kit (CS0410 from Sigma Aldrich, Saint Louis, MO, USA); corn oil; and naphthalene (147141-25G, 99% from Sigma Aldrich BVBA, Overijse, Belgium).

2.3. Naphthalene Exposure

Snails were exposed to a dose of 200 mg/kg of naphthalene. This dose was selected based on data published in rodents, for which an intramuscular dose of 200 mg/kg was most frequently used in respiratory toxicity studies [30,32,41,42,48]. More precisely, Helix aspersa maxima individuals received an intramuscular injection of 200 mg/kg of naphthalene, corresponding to 4 mg for a 20 g weighted snail. Injections were applied in the ¾ posterior part of the foot to minimize the risk of damaging any vital body organ with the needle while allowing a systemic distribution of the test compound after its absorption in the hemolymph according to an internal procedure described elsewhere (Devalckeneer et al., 2024) [49]. Three exposure groups with a minimum of 12 snails each were constituted as follows: in the “24 h Group”, animals were exposed to one single dose of naphthalene during 24 h and then euthanized; in the “4 days Group”, the individuals were exposed to one shot of naphthalene and then euthanized after 4 days; and finally, in the “Daily Group”, the individuals received a daily dose of naphthalene for 4 consecutive days before euthanasia. Hemolymph was sampled after 24 h and 4 days of daily exposure, and 6 snails from each group were euthanized by freezing them at −20 °C. Snails were dissected on ice to sample the pulmonary membrane. Tissue samples were immediately frozen in liquid nitrogen and stored at −80 °C until further GST activity measurements (n = 6 per group) and 1H-NMR spectroscopy analysis (n = 6 per group).
Control individuals (n = 6 per group) were exposed to corn oil, the vehicle used for the injection of naphthalene-containing solutions, following the same protocol. For each tested group, a matching control group was used.

2.4. Hemolymph Sampling

The procedure used in this study is based on the validated protocol previously described in Cooper (1993) [50].
Briefly, snails were washed in cold water to remove feces and excess mucus before hemolymph sampling. Snails were placed upside down, and a 25 G needle was inserted just below the pneumostome to allow hemolymph to flow out. A volume of 500 µL of a pale blue-colored liquid corresponding to hemolymph was collected in Eppendorf tubes. Amicon® Ultra-0.5 Centrifugal Filter Devices (Millipore, Burlington, MA, USA) were rinsed four times with 500 μL of demineralized water and centrifuged for 15 min at 14,000× g. Then, 500 µL of filtered hemolymph was centrifuged (30 min at 14,000× g) before adding 250 µL D2O and centrifuged again (30 min at 14,000× g). Filtrates were kept at −80 °C until 1H-NMR analysis.

2.5. Measurement of GST Activity

The procedure used in this study was based on a commercially available colorimetric GST assay kit CS0410 (Sigma Aldrich, BVBA, Overijse, Belgium) using the conjugation of the thiol group of glutathione to the 1-chloro-2,4-dinitrobenzene (CDNB) substrate.

2.5.1. Sample Preparation

A sample of 200 mg of pulmonary membrane, kept at −80 °C, was crushed into powder in a mortar with liquid nitrogen and extracted with 2 mL of cold 0.1 M phosphate buffer with EDTA. The mixture was then vortexed and sonicated for 40 s (6% amplitude) at 4 °C before centrifugation (30 min at 1500× g, 4 °C). The supernatant was collected and centrifuged (15 min at 4000× g, 4 °C) to repeat the procedure with a final centrifugation of the supernatant (10 min at 10,000× g). This final supernatant, corresponding to the cytosolic fraction, was used to measure the GST activity.

2.5.2. GST Assay

A volume of 4 µL of prepared pulmonary sample was mixed with 196 µL of reaction solution (GSH 200 mM, CDNB 100 mM in Dulbecco buffer) just before the measurement at the onset of the reaction. Blank was measured with 200 µL of reaction solution. All measurements were performed in triplicates at 380 nm and recorded every minute for 15 min (FLUOstar OPTIMA spectrophotometer). The net GST activity was calculated by subtracting the non-enzymatic reaction given by the blank sample and the kinetic activity represented by the slope of the curve. This net activity was converted into specific enzymatic activity by considering the extinction molar coefficient of the thiol group and volumes used. The results were normalized against the protein content given by the Bradford method with bovine serum albumin (BSA) as standard. Statistical analysis was performed using a Mann–Whitney–Wilcoxon test using R software. version 4.5.0.

2.6. 1H-NMR Spectroscopy and Spectral Data Analysis

The procedure of sample preparation and 1H-NMR spectroscopy on tissue extracts used in this study is based on previous studies of Helix aspersa maxima tissues [51].

2.6.1. Sample Preparation and Acquisition of Metabolic Profiles

Pulmonary membrane tissue samples preserved at −80 °C were crushed in a mortar with liquid nitrogen into powder and were extracted with precooled solutions according to the methanol–water–chloroform extraction method (1:1:0.8 v/v). The top aqueous phase was recovered, and methanol was removed in vacuo for 6 h. Each extract was reconstituted in 700 µL of phosphate buffer–D2O 0.1 M, and 50 µL of TSP (D4-trimethylsilyl propionic acid) 7 mM was added to 650 µL supernatant after final centrifugation. Regarding hemolymph samples, 600 µL of previously filtered preparations were mixed with 100 µL of TSP 4 mM. TSP prepared in 100% D2O was used as an external reference for the calibration of the NMR spectra. The singlet resonance arising from the -CH3 groups in TSP was arbitrarily fixed at 0.00 ppm for further spectral calibration. Finally, 700 µL of each sample was transferred into individual tubes (5 mm diameter) for NMR analysis.
One-dimensional NMR spectra of extracts were acquired on a Bruker (Billerica, MA, USA) 600 Avance spectrometer (11,8 T corresponding to a proton Larmor frequency of 600 MHz) at 297 K using a NOESYPRESAT-1d pulse sequence. A total of 128 free induction decays (FIDs) with 65.536 data points per FID were collected for tissue extract using a spectral width of 10.330,578 Hz, an acquisition time of 3.17 s, and a pulse recycle delay of 3 s.

2.6.2. Statistical Analysis

Discriminant metabolites were extracted with the variable importance in projection (VIP) list of the supervised PLS-DA model (partial least squares discriminant analysis), which identifies those with a cut-off VIP score ≥ 1 as mainly contributing to the clustering. A Mann–Whitney–Wilcoxon statistical test was applied to the AUC (area under the curve) values on those VIPs to assess the significance of metabolites responsible for intergroup differences (p-value < 0.05 significance level) between the naphthalene exposure group and the corresponding control group. The non-parametric Wilcoxon statistical test was chosen considering the semi-quantitative data provided by AUC values.

3. Results

3.1. GST Activity in Pulmonary Membrane After Exposure to Naphthalene

The measurement of GST activity performed on pulmonary membrane extracts of Helix aspersa maxima showed slight differences between snails exposed by foot injection either to 4 mg of naphthalene or corn oil (control group). Those differences in enzyme activity were modified upwards or downwards depending on the duration of exposure to the component. Indeed, a slight 25% decrease in GST activity in the pulmonary membrane was observed in snails after 24 h of naphthalene exposure compared to controls (p-value = 0.39; α = 0.05 significance level). The measurement of GST activity 4 days after the naphthalene injection seemed to return to baseline levels. On the contrary, extracts analyzed after 4 days of daily naphthalene exposure in similar conditions showed a 38% increase in GST activity (p-value = 0.017; α = 0.05 significance level). In this experiment, although a downward trend in activity can be observed during a single-dose regimen, only repeated exposure appears to significantly increase pulmonary GST activity (Figure 1).

3.2. 1H-NMR Profiles of Pulmonary Membrane After Exposure to Naphthalene

The 1H-NMR spectra obtained from pulmonary membrane extracts of individuals exposed to naphthalene were binned, and the numerical values retrieved after integration of the descriptor regions were submitted to multivariate data analyses and compared to controls. The PLS-DA score scatter plot reported in Figure 2 reveals some clusters of samples collected from snails exposed to 4 mg of naphthalene depending on exposure time (Figure 2A). The dispersion observed among control individuals is linked to the different regimens (duration and doses of corn oil received) to which they were submitted. Nevertheless, a clear separation between the daily naphthalene-exposed group and its corresponding control (Figure 2A) can be seen.
The metabolites contributing to the clustering were identified according to their chemical shift and the multiplicity of their corresponding resonances. Peak assignments in pulmonary membrane extracts of Helix aspersa maxima obtained by 1H-NMR spectroscopy were previously described by Devalckeneer et al. (2019) [51]. Only those discriminant metabolites displaying a VIP score ≥1 were considered for further analysis.
The changes observed in the levels of those discriminant metabolites in the pulmonary membrane tissue during exposure to naphthalene are shown in the heatmap projection constructed from the mean values of metabolite integrals presented in Table 1.
Therefore, the first metabolic changes observed after 24 h of exposure to naphthalene are lactate and succinate, which showed early increased levels followed by significant decreases 4 days after the injection. As for the daily consecutive dosing regimen, those same metabolites were maintained at lower levels as well. The opposite response was observed for ornithine, which decreased during the first 24 h and then increased when evaluated 4 days later and also in the repeated dose regimen. Glutamine and glycerol levels also increased at 24 h but seemed to return to pre-test values when assessed after 4 days. In the repeated dose regimen, glutamine level also decreased contrarily to glycerol, which kept increasing. A drop in betaine occurred after 24 h and appeared to be maintained after 4 days, whereas no change was observed with daily injections. Some modifications were only detected during this first 24 h without being changed anymore afterward, such as xanthine, sarcosine, acetyl carnitine, and glucose. Although the choline level was unchanged at first, it significantly increased after 4 days and, overall, after repeated injections.
In addition, the repeated exposure to naphthalene for 4 days showed many significant changes in the pulmonary membrane of the snail, including higher levels of fucose, acetyl-lysine, asparagine, and phenylalanine, as well as lower levels of isocitrate, malonate, glycine, UDP-glucose, and AMP.

3.3. 1H-NMR Profiles of Hemolymph After Na Exposure

1H-NMR spectra of the hemolymph samples for the 24 h and daily exposure groups were submitted to multivariate data analyses and compared to their matching controls. The PLS-DA score scatter plot reported in Figure 2B reveals some clusters between the two exposed groups. VIP lists were extracted from each supervised multivariate analysis, from which only those descriptors with a VIP score ≥ 1 were pinpointed and identified according to their chemical shift and multiplicity by comparison with in-house and web databases. The heatmap projection (Table 1) was constructed from mean values integrals allowed to show their levels changes in hemolymph collected from snails exposed to naphthalene as a function of exposure duration.
Decreasing levels of lactate and acetate were detected as soon as 24 h after naphthalene injection, and those decreases were even more pronounced after 4 days of exposure. The same trend, although without reaching statistical significance, was noticed for betaine and, to a lesser extent, for choline. Isoleucine and isobutyrate showed an opposite timely response to the exposure to naphthalene, such as isopropanol, which statistically increased during the first 24 h of exposure and then slightly decreased after 4 days of daily naphthalene injections. Most of the metabolite variations were observed in hemolymph after 24 h as compared to longer exposure times. For instance, it was the case for lower levels of threonine and alanine and higher levels of methanol, which were only observed at 24 h of exposure. The metabolites behind some of the modified resonances could not be identified (chemical shifts of 6.72 and 6.74 ppm in snail hemolymph) based on the sole proton NMR information.

4. Discussion

4.1. Metabolomic Evidence for Energetic Adaptation to Naphthalene Exposure

In normal conditions, snail intermediary metabolism relies on the oxidation of glucose through glycolysis, the TCA cycle, and oxidative phosphorylation. In the case of stress, exposure to naphthalene increases the body’s energy needs, pushing the glycolytic activity and resulting in an overconsumption of glucose and excretion of larger amounts of lactate [52], as observed in our experiments. When glycolysis is no longer sufficient to satisfy energy supplies, non-carbohydrate precursors such as glycerol, lactate, or even certain amino acids during gluconeogenesis take over. Glycerol, which is released from triglyceride lipolysis, can play a role in energy rebalancing, just like alanine, a glucoforming amino acid, both of which showed early changes in our study [53].
Changes in lactate from 24 h, on the other hand, could also indicate mitochondrial damage, key organelles in cell respiration. Lactate overproduction is generally associated with tissue hypoxia. These findings are supported by a study that reported decreased glucose and increased lactate levels in lung tissue from rats with ventilator-induced lung injury [54]. This switch to anaerobic metabolism is also supported by the concomitant succinate accumulation largely described in a range of tissues underexposed to oxygen [55] and described to be a conserved hallmark of ischemia in mice, rats, rabbits, pigs, and humans [56]. Indeed, succinate is involved in numerous metabolic pathways, including cellular respiration as a component of the TCA cycle, in which it is oxidized to fumarate by the enzyme succinate dehydrogenase (SDH). This dual-role enzyme, also known as complex II in the oxidative phosphorylation chain, is described as a conserved enzyme across species since it appears to play broadly similar and essential roles in all eukaryotes [57]. Interestingly, high levels of succinate and lactate were also observed in lung extracts by Ling et al. 2014 during intramuscular naphthalene injection in mice after 48 h [48].
Accumulation of malonate, the β-carbon dicarboxylic acid and a regulatory element of β-oxidation, has already been reported in case of deficiencies of the enzyme malonyl-CoA decarboxylase (MCOD), which converts malonyl-CoA to acetyl-CoA [58,59]. This acetyl-CoA deficiency, suggested by the downward trend of acetylcarnitine at 24 h of exposure [60], could impact the pyruvate dehydrogenase (PDH) activity responsible for controlling the aerobic oxidation rate of carbohydrates, thereby interfering with glucose homeostasis [61]. Such early intensive energy needs rapidly deplete the resources, as indicated 4 days later. Indeed, this failure in energy supply is supported by a higher glycerol synthesis, needed for energy rebalancing via lipolysis, as well as the decreased succinate level of succinate, the one-carbon (1C) molecule formate, and the short-chain fatty acid acetate, that can be used as a carbon source in nutrient-limited tumor cells [62,63]. Decreasing succinate, acetate, and formate levels were also observed in the lungs and BALF of mice after i.p. injection of naphthalene [41]. However, these metabolic modifications occurred within 24 h as compared to the present snail model. The repeated dose protocol also led to disturbances in energy metabolism as evidenced by lowered alanine and lactate due to gluconeogenesis activation, succinate, isocitrate through the TCA cycle, hydroxybutyrate through ketolysis, malonate through β-oxidation, and UDP-glucose through glycogenolysis.

4.2. Metabolomic Evidence for Naphthalene-Induced Oxidative Stress, Inflammatory Effects, and Immune System Response

Choline, a component of phospholipids, is an essential amino acid for the structural integrity of cell membranes. Phosphatidylcholine, which is composed of fatty acids and glycerol, is also considered a major lung surfactant [64]. The pulmonary surfactant system present in the gas mantel of Helix aspersa mainly contains phosphatidylcholine [65]. Altered lung functions due to environmental toxicants frequently show decreasing surfactant levels, such as phosphatidylcholine, in the alveolar cells after acrolein exposure [66]. Therefore, combining the changes observed in choline and glycerol could suggest the presence of membrane damage in lung cells.
In addition, succinate is known to accumulate in tissues during pathophysiological states such as acute lung injury or respiratory distress, even if its role is not well defined [67]. This accumulation, also observed after 48 h in mice treated with naphthalene [48], could be linked to alterations in SDH enzyme activity contributing to the oxidative stress via reversal electron transport [68,69,70,71], which have been recently shown to play key roles in promoting the pro-inflammatory phenotype [72], or even the oncogenesis pathway. Indeed, SDH inhibition disturbs the balance with α-ketoglutarate, playing a critical mediator role in the hypoxic response [73] by stabilization of hypoxia-inducible factors (HIFs) [74], well-known triggers of tumorigenesis [73,75,76] and described in pulmonary fibrosis [77]. The changes in malonate, a competitive inhibitor of SDH, support our interpretation of succinate accumulation.
Our findings also suggest different structural modifications of biomolecules. Fucose, a deoxy hexose involved in fucosylation, plays a critical role in cell signaling, immune response, and cell adhesion [78]. Data suggest that airway epithelial cells directly respond to allergens by increasing fucosylation [79]. Lysine acetylation emerged as a key regulatory mechanism, underscoring its physiological relevance in gene regulation, cell signaling, cell growth metabolism, and disease [80]. This post-translational modification of histones, recently extended to many other proteins, can modulate immune activity in various ways [81]. Therefore, increasing fucose and N-acetyl-lysine after cumulated doses of naphthalene could suggest an activation of the immune system. Other metabolic changes also support the hypothesis of a naphthalene-induced immune system response. For example, it has been demonstrated that higher production of defense cells is correlated with higher sources of glutamine [82], a metabolite synthesized in lungs through glutamine synthase, and consistently tends to increase across our experiments [83].
When the impact of repeated doses of naphthalene was assessed, some clues on enhanced anti-oxidative capacity were noticed. First, the modified glycine levels were indicative of an alteration in the biosynthesis of glutathione, a powerful antioxidant molecule. This effect was reflected in sarcosine, the methylated form of glycine synthesized through the folate cycle, and betaine, a scavenger of excess ROS and a methyl donor to generate S-adenosylmethionine (SAM). Choline, which also participates in methylation reactions following oxidation to betaine by the choline dehydrogenase, is considered a major source of 1C units, metabolism formed by the interconnection of methionine and folate cycles. These pathways, conserved from yeast to mammals [84], are known to support multiple physiological processes, including biosynthesis (purines and thymidine), amino acid homeostasis (glycine, serine, and methionine), epigenetic maintenance, and redox defense [85].
As a precursor of putrescine following its decarboxylation, ornithine is involved in the polyamine pathway recognized for its crucial role in ROS homeostasis [86]. Moreover, changes in inosine, a purine nucleoside involved in adenosine metabolism, indicate a higher polyamine synthesis but a slowdown in glycolysis [87]. Interestingly, inosine has already been reported for its anti-inflammatory properties [88,89], especially in lung inflammation [90].
Most of those metabolic changes were seen in the pulmonary membrane extract compared to a few metabolites emerging in hemolymph, such as isopropanol, lactate, and acetate. After cumulated doses, changes in isoleucine, a branched-chain amino acid (BCAA) and nitrogen donor, could reflect a higher rate of protein biosynthesis and nucleic acid production, respectively. Short-chain fatty acids (SCFAs) such as isobutyrate are known to reduce inflammatory risk by direct interactions with the immune system via responsible receptors [91]. These various mechanisms of action can reduce the number and migration ability of immune cells [92,93].
In conclusion (Figure 3), the results of this study suggest that the global energy metabolism of snails adapts to naphthalene exposure by switching to anaerobic metabolism following possible hypoxia after 24 h of exposure to naphthalene. After four days of exposure, this energy metabolism appears to be exhausted, and oxidative stress and membrane damage occur. Cellular damage caused by oxidative stress is a well-known mechanism of naphthalene toxicity following its metabolism into reactive compounds. In addition, our findings support a possible alteration in purine metabolism as well as an activation of the immune system via the promotion of defense cells fueled by 1C and glutamine metabolisms in response to stress.

4.3. A Tug of War for Nutrients in Highly Proliferative Cells?

Although the primary objective of this study was the evaluation of respiratory effects in snails exposed to naphthalene, it appeared that many changes could be associated with the support of the important metabolic activity of highly proliferative cells. In fact, both immune and tumorigenic cells seem to use the same nutrient metabolic pathways, leading to the questioning of the possible dual interpretation of our metabolomic findings.
As a matter of fact, the demands in 1C metabolism promoting defense cells could also provide essential nutrients for the tumorigenic microenvironment [94,95]. Indeed, cell proliferation of tumor growth leads to a depletion of endogenous sources of single-carbon units, which support nucleotide biosynthesis [95,96,97,98]. So, tumor progression is characterized by abnormal levels of choline-containing compounds [99]. Moreover, many metabolites have been discovered in the lung tumorigenic process, including lower levels of formate, sarcosine, and glutamate [95], and a concomitant increase in glutamine and asparagine [100,101,102] due to the upregulation of asparagine synthase [101] or an increase in ornithine produced from the hydrolysis of arginine during the urea cycle [103]. The supply of arginine in the tumor environment is the subject of competition between immune and tumor cells; the latter increases its catabolism in ornithine to the benefit of their proliferation [104]. Indeed, studies have revealed that increased polyamine levels can also attenuate anti-tumor functions of immune cells to the benefit of tumor cells [105]. Likewise, inosine, which limits the immune cell activity versus tumorigenic cells [106,107], has been reported in high levels in patients with lung squamous cell carcinoma [108]. Emerging research in glycomics has again highlighted that the tumorigenic phenotype often exhibits abnormal glycosylation [109], including fucosylation [110], as suggested by a high requirement of fucose in lung tumors [111,112,113]. In the same way, proteins from post-translational modifications (PTM), including lysine-acetylation [114], support this phenotype whether via high aberrant histone acetylation, which can deregulate chromatin-based processes or via that of non-histone proteins, especially transcription factors [115,116,117]. Perturbations in BCAA blood concentrations are also a hallmark of tumor growth, as malignant cells rely on their release through protein breakdown for proliferation. Changes in isopropanol, glycerol, and isoleucine detected in the hemolymph of naphthalene-exposed snails were also reported in plasma of lung cancer patients [118,119], isoleucine, especially, positively correlated with the squamous cell lung cancer risk [120].
Therefore, future studies should imply additional indicators of tumorigenesis to validate the link between the early metabolic markers observed in this study and tumor development in this invertebrate model.

4.4. GST Analysis in Pulmonary Membrane

Glutathione (GSH) is the major non-enzymatic antioxidant in animal cells, involved in the protective metabolism of cells against endogenous and exogenous compounds. In addition to its role as a reducing agent, it is essential for phase II conjugation detoxification reactions catalyzed by GST.
Many publications have reported an airway epithelial tolerance with repeated exposures to naphthalene, either by inhalation or intraperitoneal injection, generally after seven days in mice [121,122]. This naphthalene tolerance, specific to the respiratory tract, is declared by an injury resistance through a significant elevation in GSH levels in lung-protected tissues compared to its depletion observed when cell damage occurred [123,124]. GST plays a key role in detoxifying the cytotoxic effects of activated naphthalene metabolites during phase I; this GSH-dependent tolerance likely proceeds via GST catalysis [125]. Indeed, studies have revealed that the expression of GST isoenzymes in the lungs of naphthalene-tolerant mice differed from controls [43].
In this study, decreased GST activity observed after 24 h of naphthalene exposure suggests either that GSH is not sufficient anymore to sustain the catalytic reaction of GST conjugation or a stock depletion of GSH used for the detoxification mechanism within the first 24 h. A decrease in GSH leading to reduced GST activity was already observed with acute exposures in lung bronchial cells and mice, but in the case of iron nanoparticle treatment [126]. Conversely, the high activity detected after cumulative naphthalene injections suggests an enhanced detoxification process against pro-oxidative forces and tissue protection from injuries. Nevertheless, studies on mice have revealed that hepatic GST was essentially responsible for naphthalene tolerance compared to its pulmonary contribution, which was not highly increased.

5. Conclusions

Numerous biomarkers involved in lung injury in mammal studies were detected in snails exposed to naphthalene, especially with daily exposure. Many of them could suggest inflammatory or tumorigenic pathways via nutrient sources for proliferative cells and impairment of membrane integrity. GST activity in the pulmonary membrane suggested a stock depletion of GSH in the first 24 h reaction as a detoxification process to an enhanced activity with repeated exposures implying resynthesis of GSH to protective reaction. In contrast, GSH or its precursors did not clearly show any implication, at least using the 1H-NMR technique.
Although early effects of naphthalene toxicity on the snail model could be observed in this study, hemolymph does not seem as relevant as lung tissue, the target of toxicity, during 1H-NMR analysis. However, the ease of use, including dissection, of this animal model compared to mammals, limited by animal ethics, would therefore meet the 3Rs law, especially during in situ surveillance.
In conclusion, this study demonstrates the potential of an approach combining a bioindicator invertebrate model, herein the Helix aspersa maxima snail, with an “omics” tool in prospective risk assessment, which could offer new research opportunities to preserve human, animal, and environmental health closely connected according to the “One Health Concept”.

6. Study Limitations and Perspectives

This preliminary study, designed as a proof-of-concept exploration of the metabolomic response of possible respiratory effects in a pulmonated invertebrate, represents a first step in the development of future metabolic biomarkers of toxicity which could be transposed from invertebrates to mammals, including humans.Clearly, some adjustments are needed, particularly at the statistical level, where a larger sample size should be used either to refine non-statistical metabolic changes extracted via VIPs or when quantitative dosages of the metabolites of interest will be assessed in future research. As for the use of 1H-NMR spectroscopy as the main analytical technique, it suffers from poor sensitivity, is insufficient for the identification of unknown resonances, and is definitely unsuitable for the observation of macromolecules. In such cases, mass spectrometry and 2D-NMR would be more suitable tools. Finally, the final interest would imply the in situ exposure of the model, which allows the exposure routes and the bioavailability of pollutants in soils to be taken into account.
Although this study was carried out in a laboratory environment as a proof of concept, it is clear that placing invertebrate individuals directly on site would allow a study closer to reality in terms of exposure routes and doses.

Author Contributions

Conceptualization, A.D.; methodology, A.D.; formal analysis, A.D.; investigation, A.D. and M.B.; resources, A.D. and J.-M.C.; data curation, A.D.; writing—original draft preparation, A.D.; writing—review and editing, J.-M.C.; supervision, J.-M.C.; funding acquisition, A.D. and J.-M.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research project (Memoris, Greewin, convention 7276) was funded by the Walloon Region, Belgium.

Institutional Review Board Statement

Ethical review and approval were waived for this study, due to the invertebrate model, such as snails, not being concerned by the animal ethics committee under the European. Legislation described below: European Law: Directive 2010/63/EU.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author(s).

Acknowledgments

The authors acknowledge C. Henoumont from UMONS for her precious contribution to this work.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
PAHPolycyclic aromatic hydrocarbon
TCATricarboxylic acid cycle
BALFBronchial alveolar lavage fluid
GSTGlutathione S-transferase
GSHGlutathione
CDNB1-chloro-2,4-dinitrobenzene
BSABovine serum albumin
D2ODeuterium oxide
TSPD4-trimethylsilyl propionic acid
FIDFree induction decay
AUCArea under the curve
PLS-DAPartial least squares discriminant analysis
VIPVariable importance in projection
AMPAdenosine monophosphate
ATPAdenosine triphosphate
MCODMalonyl-CoA decarboxylase
PDHPyruvate dehydrogenase
i.p.Intraperitoneal
SDHSuccinate dehydrogenase
HIFHypoxia-inducible factor
ROSReactive oxygen species
SAMS-adenosylmethionine
PTMPost-translational modification
BCAABranched-chain amino acid
SCFAShort-chain fatty acid

References

  1. Berger, B.; Dallinger, R. Terrestrial snails as quantitative indicators of environmental metal pollution. Environ. Monit. Assess. 1993, 25, 65–84. [Google Scholar] [CrossRef] [PubMed]
  2. Cortet, J.; Gomot-De Vauflery, A.; Poinsot-Balaguer, N.; Gomot, L.; Texier, C.; Cluzeau, D. The use of invertebrate soil fauna in monitoring pollutant effects. Eur. J. Soil Biol. 1999, 35, 115–134. [Google Scholar] [CrossRef]
  3. Kammenga, J.E.; Dallinger, R.; Donker, M.H.; Köhler, H.R.; Simonsen, V.; Triebskorn, R.; Weeks, J.M. Biomarkers in terrestrial invertebrates for ecotoxicological soil risk assessment. Environ. Contam. Toxicol. 2000, 164, 93–147. [Google Scholar] [PubMed]
  4. de Vaufleury, A.; Cœurdassier, M.; Pandard, P.; Scheifler, R.; Lovy, C.; Crini, N.; Badot, P.-M. How terrestrial snails can be used in risk assessment of soils. Environ. Toxicol. Chem. 2006, 25, 797–806. [Google Scholar] [CrossRef]
  5. Altaf, J.; Qureschi, N.A.; Siddiqui, M.J.I. Terrestrial snails as bioindicators of environmental degradation. J. Biodivers. Environ. Sci. 2017, 10, 253–264. [Google Scholar]
  6. Dhiman, V.; Pant, D. Environmental biomonitoring by snails. Biomarkers 2021, 26, 221–239. [Google Scholar] [CrossRef]
  7. Srivastava, A.K.; Singh, V.K. Snails as biological monitor (bioindicator). Asian J. Adv. Res. 2020, 3, 339–345. [Google Scholar]
  8. de Vaufleury, A. Landsnail for Ecotoxicological Assessment of Chemicals and Soil Contamination—Ecotoxicological Assessment of Chemicals and Contaminated Soils Using the Terrestrial Snail, Helix aspersa, at Various Stage of Its Life Cycle: A Review. In Environmental Indicators; Armon, R., Hänninen, O., Eds.; Springer: Dordrecht, The Netherlands, 2015. [Google Scholar] [CrossRef]
  9. Viard, B.; Pihan, F.; Promeyrat, S.; Pihan, J.-C. Integrated assessment of heavy metal (Pb, Zn, Cd) highway pollution: Bioaccumulation in soil, Graminaceae and land snails. Chemosphere 2004, 55, 1349–1359. [Google Scholar] [CrossRef] [PubMed]
  10. Abdel-Halim, K.Y.; Abo El-Saad, A.M.; Talha, M.M.; Hussein, A.A.; Bakry, N.M. Oxidative stress in the land snail Helix aspersa as an indicator organism for the ecotoxicological impacts of urban pollution with heavy metals. Chemosphere 2013, 93, 1131–1138. [Google Scholar] [CrossRef]
  11. Salih, A.H.S.H.; Hama, A.A.; Hawrami, K.A.M.; Ditta, A. The Land Snail, Eobania vermiculata, as a Bioindicator of the Heavy Metal Pollution in the Urban Areas of Sulaimani, Iraq. Sustainability 2021, 13, 13719. [Google Scholar] [CrossRef]
  12. Regoli, F.; Gorbi, S.; Fattorini, D.; Tedesco, S.; Notti, A.; Machella, N.; Bocchetti, R.; Benedetti, M.; Piva, F. Use of the Land Snail Helix aspersa as Sentinel Organism for Monitoring Ecotoxicologic Effects of Urban Pollution: An Integrated Approach. Environ. Health Perspect. 2006, 114, 63–69. [Google Scholar] [CrossRef] [PubMed]
  13. Al-Alam, J.; Millet, M.; Khoury, D.; Rodrigues, A.; Akoury, E.; Tokajian, S.; Wazne, M. Biomonitoring of PAHs and PCBs in industrial, suburban, and rural areas using snails as sentinel organisms. Environ. Sci. Pollut. Res. 2024, 31, 4970–4984. [Google Scholar] [CrossRef] [PubMed]
  14. Itziou, A.; Dimitriadis, V.K. Effects of organic pollutants on Eobania vermiculata measured with five biomarkers. Ecotoxicology 2012, 21, 1484–1494. [Google Scholar] [CrossRef] [PubMed]
  15. El-Gendy, K.S.; Gad, A.F.; Radwan, M.A. Physiological and behavioral reactions of terrestrial molluscs as indicators for evaluating pollution effects: A review. Environ. Res. 2021, 193, 110558. [Google Scholar] [CrossRef]
  16. Beeby, A. The Role of Helix Aspersa as a Major Herbivore in the Transfer of Lead Through a Polluted Ecosystem. J. Appl. Ecol. 1985, 22, 267–275. [Google Scholar] [CrossRef]
  17. Laskowski, R.; Hopkin, S.P. Accumulation of Zn, Cu, Pb and Cd in the garden snail (Helix aspersa): Implications for predators. Environ. Pollut. 1996, 91, 289–297. [Google Scholar] [CrossRef]
  18. Scheifler, R.; Gomot-de Vaufleury, A.; Toussaint, M.-L.; Badot, P.-M. Transfer and effects of cadmium in an experimental food chain involving the snail Helix aspersa and the predatory carabid beetle Chrysocarabus splendens. Chemosphere 2002, 48, 571–579. [Google Scholar] [CrossRef]
  19. Taylor, J.W. Life history of British Helices: Helix (Pomatia) aspersa Müll. J. Conchol. 1883, 4, 88–105. Available online: https://www.biodiversitylibrary.org/page/31571513 (accessed on 7 February 2010).
  20. Hamza-Chaffai, A. Usefulness of Bioindicators and Biomarkers in Pollution Biomonitoring. Int. J. Biotechnol. Wellness Ind. 2014, 3, 19–26. [Google Scholar] [CrossRef]
  21. Galloway, T.S.; Brown, R.J.; Browne, M.A.; Dissanayake, A.; Lowe, D.; Jones, M.B.; Depledge, M.H. A multibiomarker approach to environmental assessment. Environ. Sci. Technol. 2004, 38, 1723–1731. [Google Scholar] [CrossRef]
  22. Hagger, J.A.; Jones, M.B.; Paul Leonard, D.R.; Owen, R.; Galloway, T.S. Biomarkers and integrated environmental risk assessment: Are there more questions than answers? Integr. Environ. Assess. Manag. Int. J. 2006, 2, 312–329. [Google Scholar] [CrossRef]
  23. Hochachka, P.W.; Fields, J.H.A.; Mommsen, T.P. Metabolic and enzyme regulation during rest-to-work transition: A mammal versus mollusc comparison. In The Mollusca; Hochachka, P.W., Ed.; Metabolic Biochemistry and Molecular Biomechanics; Elsevier: Amsterdam, The Netherlands, 1983; Volume 1, pp. 55–89. [Google Scholar]
  24. Stuart, J.A.; Ballantyne, J.S. Subcellular organization of intermediary metabolism in the hepatopancreas of the terrestrial snail, Cepaea nemoralis: A cytosolic β-hydroxybutyrate dehydrogenase. J. Exp. Zool. 1996, 274, 291–299. [Google Scholar] [CrossRef]
  25. Pradhan, S.; Das, A.; Meena, R.; Nanda, R.K.; Rajamani, P. Biofluid metabotyping of occupationally exposed subjects to air pollution demonstrates high oxidative stress and deregulated amino acid metabolism. Sci. Rep. 2016, 6, 35972. [Google Scholar] [CrossRef]
  26. Vlaanderen, J.J.; Janssen, N.A.; Hoek, G.; Keski-Rahkonen, P.; Barupal, D.K.; Cassee, F.R.; Gosens, I.; Strak, M.; Steenhof, M.; Lan, Q.; et al. The influence of ambient air pollution on the human blood metabolome. Environ. Res. 2017, 156, 341–348. [Google Scholar] [CrossRef]
  27. Surowiec, I.; Karimpour, M.; Gouveia-Figueira, S.; Wu, J.; Unosson, J.; Bosson, J.A.; Blomberg, A.; Pourazar, J.; Sandström, T.; Behndig, A.F.; et al. Multi-platform metabolomics assays for human lung lavage fluids in an air pollution exposure study. Anal. Bioanal. Chem. 2016, 408, 4751–4764. [Google Scholar] [CrossRef]
  28. Ran, Z.; An, Y.; Zhou, J.; Yang, J.; Zhang, Y.; Yang, J.; Wang, L.; Li, X.; Lu, D.; Zhong, J.; et al. Subchronic exposure to concentrated ambient PM2.5 disrupts gut and lung microbiota as well as metabolic profiles in mice. Environ. Pollut. 2021, 272, 115987. [Google Scholar] [CrossRef] [PubMed]
  29. Mahvi, D.; Bank, H.; Harley, R. Morphology of a naphthalene-induced bronchiolar lesion. Am. J. Pathol. 1977, 86, 558–572. [Google Scholar] [PubMed]
  30. Van Winkle, L.S.; Nishio, S.J.; Brown, C.D.; Plopper, C.G. Early Events in Naphthalene-Induced Acute Clara Cell Toxicity, Comparison of Membrane Permeability and Ultrastructure. Am. J. Respir. Cell Mol. Biol. 1999, 21, 44–53. [Google Scholar] [CrossRef]
  31. West, J.A.A.; Pakehham, G.; Morin, D.; Fleschner, C.A.; Buckpitt, A.R.; Plopper, C.G. Inhaled Naphthalene Causes Dose Dependent Clara Cell Cytotoxicity in Mice but Not in Rats. Toxicol. Appl. Pharmacol. 2001, 173, 114–119. [Google Scholar] [CrossRef]
  32. Aoshiba, K.; Tsuji, T.; Itoh, M.; Semba, S.; Yamaguchi, K.; Nakamura, H.; Watanabe, H. A murine model of airway fibrosis induced by repeated naphthalene exposure. Exp. Toxicol. Pathol. 2014, 66, 169–177. [Google Scholar] [CrossRef]
  33. Recio, L.; Shepard, K.G.; Hernández, L.G.; Kedderis, G.L. Dose-Response Assessment of Naphthalene-Induced Genotoxicity and Glutathione Detoxication in Human TK6 Lymphoblasts. Toxicol. Sci. 2012, 126, 405–412. [Google Scholar] [CrossRef]
  34. Richieri, P.R.; Buckpitt, A.R. Efflux of naphthalene oxide and reactive naphthalene metabolites from isolated hepatocytes. J. Pharmacol. Exp. Ther. 1987, 242, 485–492. [Google Scholar] [CrossRef] [PubMed]
  35. Kanekal, S.; Plopper, C.; Morin, D.; Buckpitt, A. Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung. J. Pharmacol. Exp. Ther. 1991, 256, 391–401. [Google Scholar] [CrossRef]
  36. Albuquerque, T.A.F.; Drummond do Val, L.; Doherty, A.; de Magalhães, J.P. From humans to hydra: Patterns of cancer across the tree of life. Biol. Rev. Camb. Philos. Soc. 2018, 93, 1715–1734. [Google Scholar] [CrossRef] [PubMed]
  37. Tascedda, F.; Ottaviani, E. Tumors in invertebrates. Invertebr. Surviv. J. 2014, 11, 197–203. [Google Scholar]
  38. Scharrer, B.; Lochhead, M.S. Tumors in the invertebrates: A review. Cancer Res. 1950, 10, 403–419. [Google Scholar] [PubMed]
  39. Robert, J. Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates. Dev. Comp. Immunol. 2010, 34, 915–925. [Google Scholar] [CrossRef]
  40. Richards, C.S. Tumors in the pulmonary cavity of Biomphalaria glabrata: Genetic studies. J. Invertebr. Pathol. 1973, 22, 283–289. [Google Scholar] [CrossRef]
  41. Hong, J.-H.; Lee, W.-C.; Hsu, Y.-M.; Liang, H.-J.; Wan, C.-H.; Chien, C.-L.; Lin, C.-Y. Characterization of the biochemical effects of naphthalene on the mouse respiratory system using NMR-based metabolomics. J. Appl. Toxicol. 2014, 34, 1379–1388. [Google Scholar] [CrossRef]
  42. Lin, C.-Y.; Huang, F.-P.; Ling, Y.S.; Liang, H.-J.; Lee, S.-H.; Hu, M.-Y.; Tsao, P.-N. Use of Nuclear Magnetic Resonance-Based Metabolomics to Characterize the Biochemical Effects of Naphthalene on Various Organs of Tolerant Mice. PLoS ONE 2015, 10, e0120429. [Google Scholar] [CrossRef]
  43. Mitchell, A.; Lakritz, J.; Jones, A. Quantification of individual glutathione S-transferase isozymes in hepatic and pulmonary tissues of naphthalene-tolerant mice. Arch. Toxicol. 2000, 74, 215–221. [Google Scholar] [CrossRef] [PubMed]
  44. Baldwin, R.M.; Shultz, M.A.; Buckpitt, A.R. Bioactivation of the Pulmonary Toxicants Naphthalene and 1-Nitronaphthalene by Rat CYP2F4. J. Pharmacol. Exp. Ther. 2005, 312, 857–865. [Google Scholar] [CrossRef] [PubMed]
  45. Ritchie, K.J.; Henderson, C.J.; Wang, X.J.; Vassieva, O.; Carrie, D.; Farmer, P.B.; Gaskell, M.; Park, K.; Wolf, C.R. Glutathione Transferase π Plays a Critical Role in the Development of Lung Carcinogenesis following Exposure to Tobacco-Related Carcinogens and Urethane. Cancer Res. 2007, 67, 9248–9257. [Google Scholar] [CrossRef] [PubMed]
  46. Bocedi, A.; Noce, A.; Marrone, G.; Noce, G.; Cattani, G.; Gambardella, G.; Di Lauro, M.; Di Daniele, N.; Ricci, G. Glutathione Transferase P1-1 an Enzyme Useful in Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution. Nutrients 2019, 11, 1741. [Google Scholar] [CrossRef]
  47. Ismert, M.; Oster, T.; Bagrel, D. Effects of atmospheric exposure to naphthalene on xenobiotic-metabolising enzymes in the snail Helix aspersa. Chemosphere 2002, 46, 273–280. [Google Scholar] [CrossRef]
  48. Ling, Y.S.; Liang, H.J.; Chung, M.H.; Lin, M.H.; Lin, C.Y. NMR-and MS-based metabolomics: Various organ responses following naphthalene intervention. Mol. Biosyst. 2014, 10, 1918–1931. [Google Scholar] [CrossRef]
  49. Devalckeneer, A.; Bouviez, M.; Gautier, A.; Colet, J.-M. Metabolomic Prediction of Cadmium Nephrotoxicity in the Snail Helix aspersa maxima. Metabolites 2024, 14, 455. [Google Scholar] [CrossRef]
  50. Cooper, J.E. Bleeding of pulmonate snails. Lab. Anim. 1994, 28, 277–278. [Google Scholar] [CrossRef]
  51. Aude, D.; Marion, B.; Raphaël, C.; Colet, J.-M. Proton Nuclear Magnetic Resonance (1H NMR) profiling of isolated organs in the snail Helix aspersa maxima. Ecol. Indic. 2019, 105, 177–187. [Google Scholar] [CrossRef]
  52. Vander Heiden, M.G.; Cantley, L.C.; Thompson, C.B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009, 324, 1029–1033. [Google Scholar] [CrossRef] [PubMed]
  53. Felig, P. The glucose-alanine cycle. Metab.—Clin. Exp. 1973, 22, 179–207. [Google Scholar] [CrossRef] [PubMed]
  54. Xiong, Z.; Wang, Y.; Lang, L.; Ma, S.; Zhao, L.; Xiao, W.; Wang, Y. Tissue metabolomic profiling to reveal the therapeutic mechanism of reduning injection on LPS-induced acute lung injury rats. RSC Adv. 2018, 8, 10023–10031. [Google Scholar] [CrossRef] [PubMed]
  55. Chouchani, E.T.; Pell, V.R.; Gaude, E.; Aksentijević, D.; Sundier, S.Y.; Robb, E.L.; Logan, A.; Nadtochiy, S.M.; Ord, E.N.J.; Smith, A.C.; et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014, 515, 431–435. [Google Scholar] [CrossRef] [PubMed]
  56. Prag, H.A.; Murphy, M.P.; Krieg, T. Preventing mitochondrial reverse electron transport as a strategy for cardioprotection. Basic Res. Cardiol. 2023, 118, 34. [Google Scholar] [CrossRef]
  57. Bénit, P.; Kahn, A.; Chretien, D.; Bortoli, S.; Huc, L.; Schiff, M.; Gimenez-Roqueplo, A.-P.; Favier, J.; Gressens, P.; Rak, M.; et al. Evolutionarily conserved susceptibility of the mitochondrial respiratory chain to SDHI pesticides and its consequence on the impact of SDHIs on human cultured cells. PLoS ONE 2019, 14, e0224132. [Google Scholar] [CrossRef]
  58. Ersoy, M.; Akyol, M.B.; Ceylaner, S.; Biçer, N.Ç. A novel frameshift mutation of malonyl-CoA decarboxylase deficiency: Clinical signs and therapy response of a late-diagnosed case. Clin. Case Rep. 2017, 5, 1284. [Google Scholar] [CrossRef]
  59. Hendrickson, C.; Linden, K.; Kreyer, S.; Beilman, G.; Scaravilli, V.; Wendorff, D.; Necsoiu, C.; Batchinsky, A.I.; Cancio, L.C.; Chung, K.K.; et al. 1H-NMR metabolomics identifies significant changes in metabolism over time in a porcine model of severe burn and smoke inhalation. Metabolites 2019, 9, 142. [Google Scholar] [CrossRef]
  60. Lindeboom, L.; Nabuurs, C.I.; Hoeks, J.; Brouwers, B.; Phielix, E.; Kooi, M.E.; Hesselink, M.K.; Wildberger, J.E.; Stevens, R.D.; Koves, T.; et al. Long–echo time MR spectroscopy for skeletal muscle acetylcarnitine detection. J. Clin. Investig. 2014, 124, 4915–4925. [Google Scholar] [CrossRef]
  61. Constantin-Teodosiu, D.; Carlin, J.I.; Cederblad, G.; Harrist, R.C.; Hultman, E. Acetyl group accumulation and pyruvate dehydrogenase activity in human muscle during incremental exercise. Acta Physiol. Scand. 1991, 143, 367–372. [Google Scholar] [CrossRef]
  62. Yoshii, Y.; Furukawa, T.; Yoshii, H.; Mori, T.; Kiyono, Y.; Waki, A.; Kobayashi, M.; Tsujikawa, T.; Kudo, T.; Okazawa, H.; et al. Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: The possible function in tumor acetyl-CoA/acetate metabolism. Cancer Sci. 2009, 100, 821–827. [Google Scholar] [CrossRef]
  63. Bulusu, V.; Tumanov, S.; Michalopoulou, E.; van den Broek, N.J.; Mackay, G.; Nixon, C.; Dhayade, S.; Schug, Z.; Voorde, J.V.; Blyth, K.; et al. Acetate recapturing by nuclear acetyl-CoA synthetase 2 prevents loss of histone acetylation during oxygen and serum limitation. Cell Rep. 2017, 18, 647–658. [Google Scholar] [CrossRef] [PubMed]
  64. Agassandian, M.; Mallampalli, R.K. Surfactant phospholipid metabolism. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2013, 1831, 612–625. [Google Scholar] [CrossRef]
  65. Daniels, C.B.; Wood, P.G.; Lopatko, O.V.; Codd, J.R.; Johnston, S.D.; Orgeig, S. Surfactant in the gas mantle of the snail Helix aspersa. Physiol. Biochem. Zool. 1999, 72, 691–698. [Google Scholar] [CrossRef] [PubMed]
  66. Agarwal, A.R.; Yin, F.; Cadenas, E. Metabolic shift in lung alveolar cell mitochondria following acrolein exposure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013, 305, 764–773. [Google Scholar] [CrossRef] [PubMed]
  67. Taghavi, S.; Campbell, A.; Engelhardt, D.; Duchesne, J.; Shaheen, F.; Pociask, D.; Kolls, J.; Jackson-Weaver, O. Dimethyl malonate protects the lung in a murine model of acute respiratory distress syndrome. J. Trauma Acute Care Surg. 2024, 96, 386–393. [Google Scholar] [CrossRef]
  68. Zhang, Y.; Zhang, M.; Zhu, W.; Yu, J.; Wang, Q.; Zhang, J.; Cui, Y.; Pan, X.; Gao, X.; Sun, H. Succinate accumulation induces mitochondrial reactive oxygen species generation and promotes status epilepticus in the kainic acid rat model. Redox Biol. 2020, 28, 101365. [Google Scholar] [CrossRef]
  69. Altea-Manzano, P.; Vandekeere, A.; Edwards-Hicks, J.; Roldan, M.; Abraham, E.; Lleshi, X.; Guerrieri, A.N.; Berardi, D.; Wills, J.; Junior, J.M.; et al. Reversal of mitochondrial malate dehydrogenase 2 enables anaplerosis via redox rescue in respiration-deficient cells. Mol. Cell 2022, 82, 4537–4547. [Google Scholar] [CrossRef]
  70. Manhas, N.; Duong, Q.V.; Lee, P.; Richardson, J.D.; Robertson, J.D.; Moxley, M.A.; Bazil, J.N. Computationally modeling mammalian succinate dehydrogenase kinetics identifies the origins and primary determinants of ROS production. J. Biol. Chem. 2020, 295, 15262–15279. [Google Scholar] [CrossRef]
  71. Kamarauskaite, J.; Baniene, R.; Trumbeckas, D.; Strazdauskas, A.; Trumbeckaite, S. Increased succinate accumulation induces ROS generation in in vivo ischemia/reperfusion-affected rat kidney mitochondria. BioMed Res. Int. 2020, 2020, 8855585. [Google Scholar] [CrossRef]
  72. Gobelli, D.; Serrano-Lorenzo, P.; Esteban-Amo, M.J.; Serna, J.; Pérez-García, M.T.; Orduña, A.; Jourdain, A.A.; Martín-Casanueva, M.Á.; de la Fuente, M.Á.; Simarro, M. The mitochondrial succinate dehydrogenase complex controls the STAT3-IL-10 pathway in inflammatory macrophages. iScience 2023, 26, 107473. [Google Scholar] [CrossRef]
  73. Bénit, P.; Goncalves, J.; El Khoury, R.; Rak, M.; Favier, J.; Gimenez-Roqueplo, A.P.; Rustin, P. Succinate dehydrogenase, succinate, and superoxides: A genetic, epigenetic, metabolic, environmental explosive crossroad. Biomedicines 2022, 10, 1788. [Google Scholar] [CrossRef]
  74. Tretter, L.; Patocs, A.; Chinopoulos, C. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochim. Biophys. Acta (BBA)-Bioenerg. 2016, 1857, 1086–1101. [Google Scholar] [CrossRef] [PubMed]
  75. Xia, L.; Zhang, H.; Wang, X.; Zhang, X.; Nie, K. The role of succinic acid metabolism in ovarian cancer. Front. Oncol. 2021, 11, 769196. [Google Scholar] [CrossRef] [PubMed]
  76. Dalla Pozza, E.; Dando, I.; Pacchiana, R.; Liboi, E.; Scupoli, M.T.; Donadelli, M.; Palmieri, M. Regulation of succinate dehydrogenase and role of succinate in cancer. Semin. Cell Dev. Biol. 2020, 98, 4–14. [Google Scholar] [CrossRef]
  77. He, Y.; Han, Y.; Zou, L.; Yao, T.; Zhang, Y.; Lv, X.; Jiang, M.; Long, L.; Li, M.; Cheng, X.; et al. Succinate promotes pulmonary fibrosis through GPR91 and predicts death in idiopathic pulmonary fibrosis. Sci. Rep. 2024, 14, 14376. [Google Scholar] [CrossRef] [PubMed]
  78. Rafique, S.; Ge, W.; Gao, Z.; Chen, Y.; Xia, J.; Jiang, J.; Yang, S. Exploring Fucosylation in Lung Cancer: Mechanisms, Diagnosis, and Therapeutic Strategies. Adv. Biomark. Sci. Technol. 2024, 6, 174–190. [Google Scholar] [CrossRef]
  79. Alvarez, C.A.; Qian, E.; Glendenning, L.M.; Reynero, K.M.; Kukan, E.N.; Cobb, B.A. Acute and chronic lung inflammation drives changes in epithelial glycans. Front. Immunol. 2023, 14, 1167908. [Google Scholar] [CrossRef]
  80. Ali, I.; Conrad, R.J.; Verdin, E.; Ott, M. Lysine acetylation goes global: From epigenetics to metabolism and therapeutics. Chem. Rev. 2018, 118, 1216–1252. [Google Scholar] [CrossRef]
  81. Ding, P.; Ma, Z.; Liu, D.; Pan, M.; Li, H.; Feng, Y.; Zhang, Y.; Shao, C.; Jiang, M.; Lu, D.; et al. Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy. Front. Immunol. 2022, 13, 865975. [Google Scholar] [CrossRef]
  82. Calder, P.C.; Yaqoob, P. Glutamine and the immune system. Amino Acids 1999, 17, 227–241. [Google Scholar] [CrossRef]
  83. Karinch, A.M.; Pan, M.; Lin, C.M.; Strange, R.; Souba, W.W. Glutamine metabolism in sepsis and infection. J. Nutr. 2001, 131, 2535S–2538S. [Google Scholar] [CrossRef] [PubMed]
  84. Tibbetts, A.S.; Appling, D.R. Compartmentalization of Mammalian Folate-Mediated One-Carbon Metabolism. Annu. Rev. Nutr. 2010, 30, 57–81. [Google Scholar] [CrossRef]
  85. Ducker, G.S.; Rabinowitz, J.D. One-carbon metabolism in health and disease. Cell Metab. 2017, 25, 27–42. [Google Scholar] [CrossRef] [PubMed]
  86. Stewart, T.M.; Dunston, T.T.; Woster, P.M.; Casero, R.A., Jr. Polyamine catabolism and oxidative damage. J. Biol. Chem. 2018, 293, 18736–18745. [Google Scholar] [CrossRef] [PubMed]
  87. Klysz, D.D.; Fowler, C.; Malipatlolla, M.; Stuani, L.; Freitas, K.A.; Chen, Y.; Meier, S.; Daniel, B.; Sandor, K.; Xu, P.; et al. Inosine induces stemness features in CAR-T cells and enhances potency. Cancer Cell 2024, 42, 266–282. [Google Scholar] [CrossRef] [PubMed]
  88. Wang, T.; Gnanaprakasam, J.N.R.; Chen, X.; Kang, S.; Xu, X.; Sun, H.; Liu, L.; Rodgers, H.; Miller, E.; Cassel, T.A.; et al. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nat. Metab. 2020, 2, 635–647. [Google Scholar] [CrossRef]
  89. Kim, I.S.; Jo, E.K. Inosine: A bioactive metabolite with multimodal actions in human diseases. Front. Pharmacol. 2022, 13, 1043970. [Google Scholar] [CrossRef]
  90. da Rocha Lapa, F.; de Oliveira, A.P.L.; Accetturi, B.G.; de Oliveira Martins, I.; Domingos, H.V.; de Almeida Cabrini, D.; de Lima, W.T.; Santos, A.R.S. Anti-inflammatory effects of inosine in allergic lung inflammation in mice: Evidence for the participation of adenosine A 2A and A 3 receptors. Purinergic Signal. 2013, 9, 325–336. [Google Scholar] [CrossRef]
  91. Chalova, P.; Tazky, A.; Skultety, L.; Minichova, L.; Chovanec, M.; Ciernikova, S.; Mikus, P.; Piestansky, J. Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: A review. Front. Oncol. 2023, 13, 1110235. [Google Scholar] [CrossRef]
  92. Yao, Y.; Cai, X.; Fei, W.; Ye, Y.; Zhao, M.; Zheng, C. The role of short-chain fatty acids in immunity, inflammation and metabolism. Crit. Rev. Food Sci. Nutr. 2022, 62, 1–12. [Google Scholar] [CrossRef]
  93. Kim, C.H.; Park, J.; Kim, M. Gutmicrobiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw. 2014, 14, 277. [Google Scholar] [CrossRef]
  94. Meiser, J.; Vazquez, A. Give it or take it: The flux of one-carbon in cancer cells. FEBS J. 2016, 283, 3695–3704. [Google Scholar] [CrossRef]
  95. Pietzke, M.; Arroyo, S.F.; Sumpton, D.; Mackay, G.M.; Martin-Castillo, B.; Camps, J.; Joven, J.; Menendez, J.A.; Vazquez, A.; On behalf of the METTEN study group. Stratification of cancer and diabetes based on circulating levels of formate and glucose. Cancer Metab. 2019, 7, 3. [Google Scholar] [CrossRef] [PubMed]
  96. Labuschagne, C.F.; Van Den Broek, N.J.; Mackay, G.M.; Vousden, K.H.; Maddocks, O.D. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 2014, 7, 1248–1258. [Google Scholar] [CrossRef] [PubMed]
  97. Geeraerts, S.L.; Heylen, E.; De Keersmaecker, K.; Kampen, K.R. The ins and outs of serine and glycine metabolism in cancer. Nat. Metab. 2021, 3, 131–141. [Google Scholar] [CrossRef]
  98. Jain, M.; Nilsson, R.; Sharma, S.; Madhusudhan, N.; Kitami, T.; Souza, A.L.; Kafri, R.; Kirschner, M.W.; Clish, C.B.; Mootha, V.K. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012, 336, 1040–1044. [Google Scholar] [CrossRef] [PubMed]
  99. Glunde, K.; Bhujwalla, Z.M.; Ronen, S.M. Choline metabolism in malignant transformation. Nat. Rev. Cancer 2011, 11, 835–848. [Google Scholar] [CrossRef]
  100. Sappington, D.R.; Siegel, E.R.; Hiatt, G.; Desai, A.; Penney, R.B.; Jamshidi-Parsian, A.; Griffin, R.J.; Boysen, G. Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines. Biochim. Biophys. Acta (BBA)-Gen. Subj. 2016, 1860, 836–843. [Google Scholar] [CrossRef]
  101. Yuan, Q.; Yin, L.; He, J.; Zeng, Q.; Liang, Y.; Shen, Y.; Zu, X. Metabolism of asparagine in the physiological state and cancer. Cell Commun. Signal. 2024, 22, 163. [Google Scholar] [CrossRef]
  102. Zhang, X.; Zhu, X.; Wang, C.; Zhang, H.; Cai, Z. Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis. Oncotarget 2016, 7, 63437. [Google Scholar] [CrossRef]
  103. Chagovets, V.; Starodubtseva, N.; Tokareva, A.; Novoselova, A.; Patysheva, M.; Larionova, I.; Prostakishina, E.; Rakina, M.; Kazakova, A.; Topolnitskiy, E.; et al. Specific changes in amino acid profiles in monocytes of patients with breast, lung, colorectal and ovarian cancers. Front. Immunol. 2024, 14, 1332043. [Google Scholar] [CrossRef]
  104. Gautier, C.; Huynh, M.A.; Peron, C.; Pol, J. Des bactéries modifiées pour produire la L-arginine potentialisent l’immunothérapie des cancers. Med. Sci. 2023, 39, 793–795. [Google Scholar] [CrossRef] [PubMed]
  105. Soda, K. The mechanisms by which polyamines accelerate tumor spread. J. Exp. Clin. Cancer Res. 2011, 30, 95. [Google Scholar] [CrossRef]
  106. Pasquini, S.; Contri, C.; Borea, P.A.; Vincenzi, F.; Varani, K. Adenosine and Inflammation: Here, There and Everywhere. Int. J. Mol. Sci. 2021, 22, 7685. [Google Scholar] [CrossRef]
  107. Li, X.; Zhao, L.; Wei, M.; Lv, J.; Sun, Y.; Shen, X.; Zhao, D.; Xue, F.; Zhang, T.; Wang, J. Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma. J. Cancer 2021, 12, 3190. [Google Scholar] [CrossRef] [PubMed]
  108. Lee, H.; Lee, H.; Park, S.; Kim, M.; Park, J.Y.; Jin, H.; Oh, K.; Bae, J.; Yang, Y.; Choi, H.-K. Integrative Metabolomic and Lipidomic Profiling of Lung Squamous Cell Carcinoma for Characterization of Metabolites and Intact Lipid Species Related to the Metastatic Potential. Cancers 2021, 13, 4179. [Google Scholar] [CrossRef] [PubMed]
  109. Thomas, D.; Rathinavel, A.K.; Radhakrishnan, P. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Biochim. Biophys. Acta Rev. Cancer 2021, 1875, 188464. [Google Scholar] [CrossRef]
  110. Shan, M.; Yang, D.; Dou, H.; Zhang, L. Fucosylation in cancer biology and its clinical applications. Prog. Mol. Biol. Transl. Sci. 2019, 162, 93–119. [Google Scholar] [CrossRef]
  111. Sawke, N.G.; Sawke, G.K. Serum fucose level in malignant diseases. Indian J. Cancer 2010, 47, 452–457. [Google Scholar] [CrossRef]
  112. Sakai, T.; Yamamoto, K.; Yokota, H.; Hakozaki-Usui, K.; Hino, F.; Kato, I. Rapid, simple enzymatic assay of free L-fucose in serum and urine, and its use as a marker for cancer, cirrhosis, and gastric ulcers. Clin. Chem. 1990, 36, 474–476. [Google Scholar] [CrossRef]
  113. Jia, L.; Zhang, J.; Ma, T.; Guo, Y.; Yu, Y.; Cui, J. The function of fucosylation in progression of lung cancer. Front. Oncol. 2018, 8, 565. [Google Scholar] [CrossRef]
  114. Zhao, Q.; Zhang, Z.; Li, J.; Xu, F.; Zhang, B.; Liu, M.; Liu, Y.; Chen, H.; Yang, J.; Zhang, J. Lysine acetylome study of human hepatocellular carcinoma tissues for biomarkers and therapeutic targets discovery. Front. Genet. 2020, 11, 572663. [Google Scholar] [CrossRef]
  115. Di Martile, M.; Del Bufalo, D.; Trisciuoglio, D. The multifaceted role of lysine acetylation in cancer: Prognostic biomarker and therapeutic target. Oncotarget 2016, 7, 55789. [Google Scholar] [CrossRef] [PubMed]
  116. Singh, B.N.; Zhang, G.; Hwa, Y.L.; Li, J.; Dowdy, S.C.; Jiang, S.W. Nonhistone protein acetylation as cancer therapy targets. Expert Rev. Anticancer Ther. 2010, 10, 935–954. [Google Scholar] [CrossRef] [PubMed]
  117. Chen, L.; Miao, Y.; Liu, M.; Zeng, Y.; Gao, Z.; Peng, D.; Hu, B.; Li, X.; Zheng, Y.; Xue, Y.; et al. Pan-cancer analysis reveals the functional importance of protein lysine modification in cancer development. Front. Genet. 2018, 9, 254. [Google Scholar] [CrossRef]
  118. Derveaux, E.; Thomeer, M.; Mesotten, L.; Reekmans, G.; Adriaensens, P. Detection of Lung Cancer via Blood Plasma and 1H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor. Metabolites 2021, 11, 537. [Google Scholar] [CrossRef] [PubMed]
  119. Wang, W.; Bai, L.; Li, W.; Cui, J. The lipid metabolic landscape of cancers and new therapeutic perspectives. Front. Oncol. 2020, 10, 605154. [Google Scholar] [CrossRef]
  120. Shestakova, K.M.; Moskaleva, N.E.; Boldin, A.A.; Rezvanov, P.M.; Shestopalov, A.V.; Rumyantsev, S.A.; Zlatnik, E.Y.; Novikova, I.A.; Sagakyants, A.B.; Timofeeva, S.V.; et al. Targeted metabolomic profiling as a tool for diagnostics of patients with non-small-cell lung cancer. Sci. Rep. 2023, 13, 11072. [Google Scholar] [CrossRef]
  121. O’Brien, K.A.; Suverkropp, C.; Kanekal, S.; Plopper, C.G.; Buckpitt, A.R. Tolerance to multiple doses of the pulmonary toxicant, naphthalene. Toxicol. Appl. Pharmacol. 1989, 99, 487–500. [Google Scholar] [CrossRef]
  122. West, J.A.; Van Winkle, L.S.; Morin, D.; Fleschner, C.A.; Forman, H.J.; Plopper, C.G. Repeated inhalation exposures of the bioactivated cytotoxi-cant naphthalene (NA) produce airway specific Clara cell tolerance in mice. Toxicol. Sci. 2003, 75, 161–168. [Google Scholar] [CrossRef]
  123. Bogen, K.T.; Benson, J.M.; Yost, G.S.; Morris, J.B.; Dahl, A.R.; Clewell, H.J.; Krishnan, K.; Omiecinski, C.J. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regul. Toxicol. Pharmacol. 2008, 51, 27–36. [Google Scholar] [CrossRef] [PubMed]
  124. West, J.A.; Buckpitt, A.R.; Plopper, C.G. Elevated airway GSH resynthesis confers protection to Clara cells from naphthalene injury in mice made tolerant by repeated exposures. J. Pharmacol. Exp. Ther. 2000, 294, 516–523. [Google Scholar] [CrossRef] [PubMed]
  125. Buonarati, M.; Jones, A.D.; Buckpitt, A. In vivo metabolism of isomeric naphthalene oxide glutathione conjugates. Drug Metab. Dispos. 1990, 18, 183–189. [Google Scholar] [CrossRef] [PubMed]
  126. Zhang, W.; Gao, J.; Lu, L.; Bold, T.; Li, X.; Wang, S.; Chang, Z.; Chen, J.; Kong, X.; Zheng, Y.; et al. Intracellular GSH/GST antioxidants system change as an earlier biomarker for toxicity evaluation of iron oxide nanoparticles. NanoImpact 2021, 23, 100338. [Google Scholar] [CrossRef]
Figure 1. Illustration of the in vivo effect of naphthalene (4 mg/20 g snail) on specific GST activity in pulmonary membrane of H. aspersa maxima snails (n= 6) after 24 h, 4 days, and daily 4 days exposure. At each timepoint, the exposed group was compared to its matching control group that received corn oil (380 nm kinetic measurements, total protein normalization by Bradford technique). * α = 0.05 significance level.
Figure 1. Illustration of the in vivo effect of naphthalene (4 mg/20 g snail) on specific GST activity in pulmonary membrane of H. aspersa maxima snails (n= 6) after 24 h, 4 days, and daily 4 days exposure. At each timepoint, the exposed group was compared to its matching control group that received corn oil (380 nm kinetic measurements, total protein normalization by Bradford technique). * α = 0.05 significance level.
Metabolites 15 00448 g001
Figure 2. (A) PLS-DA score scatter plots of 1H-NMR binned data obtained from pulmonary membrane aqueous extracts from snails exposed to 4 mg of naphthalene (Na) for 24 h (in blue), after 4 days (in green) and after 4 days of daily exposure (in red) compared to their timely matching controls (in black, exposure times separated in black dotted line). (B) PLS-DA score scatter plots of 1H-NMR spectral data obtained from snail hemolymph exposed to 4 mg of naphthalene (Na) for 24 h (in blue) and daily 4 days (in red) compared to their timely control group exposed to corn oil (in black).
Figure 2. (A) PLS-DA score scatter plots of 1H-NMR binned data obtained from pulmonary membrane aqueous extracts from snails exposed to 4 mg of naphthalene (Na) for 24 h (in blue), after 4 days (in green) and after 4 days of daily exposure (in red) compared to their timely matching controls (in black, exposure times separated in black dotted line). (B) PLS-DA score scatter plots of 1H-NMR spectral data obtained from snail hemolymph exposed to 4 mg of naphthalene (Na) for 24 h (in blue) and daily 4 days (in red) compared to their timely control group exposed to corn oil (in black).
Metabolites 15 00448 g002
Figure 3. Alterations in metabolic pathways in tissue extracts of pulmonary membrane in Helix aspersa maxima following exposure to naphthalene, after 24 h (in blue), after 4 days (in green), and after 4 days of daily injections (in red). Ox: oxaloacetate, SAM: S-adenosylmethionine, SAH: S-adenosylhomocysteine, Homocys.: homocysteine, DMG: dimethylglycine, PC: phosphatidylcholine, AS: adenylosuccinate, SDH: succinate dehydrogenase.
Figure 3. Alterations in metabolic pathways in tissue extracts of pulmonary membrane in Helix aspersa maxima following exposure to naphthalene, after 24 h (in blue), after 4 days (in green), and after 4 days of daily injections (in red). Ox: oxaloacetate, SAM: S-adenosylmethionine, SAH: S-adenosylhomocysteine, Homocys.: homocysteine, DMG: dimethylglycine, PC: phosphatidylcholine, AS: adenylosuccinate, SDH: succinate dehydrogenase.
Metabolites 15 00448 g003
Table 1. Heatmaps of discriminant metabolites identified by chemical shifts (in ppm) in pulmonary tissue and hemolymph samples with either increased percentage levels (redder tone) or decreased percentage levels (greener tone) in naphthalene-exposed groups after 24 h, after 4 days, and after 4 days of daily exposure as compared to their matching controls. Significant changes are displayed in italicized bold underlined characters (Wilcoxon test, α < 0.05).
Table 1. Heatmaps of discriminant metabolites identified by chemical shifts (in ppm) in pulmonary tissue and hemolymph samples with either increased percentage levels (redder tone) or decreased percentage levels (greener tone) in naphthalene-exposed groups after 24 h, after 4 days, and after 4 days of daily exposure as compared to their matching controls. Significant changes are displayed in italicized bold underlined characters (Wilcoxon test, α < 0.05).
In Pulmonary TissueIn Hemolymph
ppmMetabolitesCTRLAfter 24 HAfter 4 Days4 Days/DailyppmMetabolitesCTRLAfter 24 H4 Days/Daily
1.2Hydroxybutyrate100 441–1.01Isoleucine10075204
1.24Fucose100 2051.08–1.1Isobutyrate10011941
1.32Lactate10015347371.17–1.18Isopropanol10015581
1.48Alanine100119 691.28–1.29Threonine10088
1.72–1.76Putrescine100 1681.17–1.20Ethanol100 84
1.78Ornithine10065 1.33–1.34Lactate1005023
1.92Acetate100106501071.45–1.47Alanine10087
2.03N-acetyl-Lysine100 1531.92Acetate1004313
2.11–2.18Glutamine1001671231243.23Choline1008968
2.34–2.37Glutamate10011083923.36Methanol100179
2.41Succinate10019730183.55–3.58Glycerol100126113
2.54Isocitrate100 273.91Betaine1001735
2.71Dimethylamine10090 6.72Unknown100119
2.73Sarcosine10057 6.74Unknown100118
2.8Aspartate100 1127.01Unknown10051
2.86Dimethylformamide100 1427.72Unknown10044
2.88Asparagine100 3007.76Unknown10050
3.04Ornithine100 122156
3.1Malonate100132 50
3.19Acetylcarnitine10067
3.21Choline10092119134
3.23Acetylcholine100898499
3.24Carnitine100109102
3.27Betaine1008386
3.56Glycine100101 59
3.65Glycerol100182145303
3.8Glucose10079
5.97UDP-Glucose100 43
6.08Adenosine100 84
6.1Inosine100 123198
6.15AMP100 20
6.52Fumarate100114101
6.88Tyrosine10092
7.33Phenylalanine100 204
7.69Unkown100 281125
7.88Uridine10098
7.9Xanthine100192
8Guanosine100 91
8.46Formate100 37
Level modifications of metabolites
Metabolites 15 00448 i001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Devalckeneer, A.; Bouviez, M.; Colet, J.-M. Metabolomic Prediction of Naphthalene Pneumo-Toxicity in the Snail Helix aspersa maxima. Metabolites 2025, 15, 448. https://doi.org/10.3390/metabo15070448

AMA Style

Devalckeneer A, Bouviez M, Colet J-M. Metabolomic Prediction of Naphthalene Pneumo-Toxicity in the Snail Helix aspersa maxima. Metabolites. 2025; 15(7):448. https://doi.org/10.3390/metabo15070448

Chicago/Turabian Style

Devalckeneer, Aude, Marion Bouviez, and Jean-Marie Colet. 2025. "Metabolomic Prediction of Naphthalene Pneumo-Toxicity in the Snail Helix aspersa maxima" Metabolites 15, no. 7: 448. https://doi.org/10.3390/metabo15070448

APA Style

Devalckeneer, A., Bouviez, M., & Colet, J.-M. (2025). Metabolomic Prediction of Naphthalene Pneumo-Toxicity in the Snail Helix aspersa maxima. Metabolites, 15(7), 448. https://doi.org/10.3390/metabo15070448

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop